Abstract
Incorporation of cytotoxic drugs into microspheres reduces but does not eliminate systemic toxicity. The extent of liver to lung shunt was measured in 26 patients with colorectal liver metastasis. Liver to lung shunting correlated with proportion of liver replacement but did not exceed 4.4% and therefore is unlikely to cause systemic toxicity.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersson M., Aronsen K. F., Balch C., Domellöf L., Eksborg S., Hafström L. O., Howell S. B., Kåresen R., Midander J., Teder H. Pharmacokinetics of intra-arterial mitomycin C with or without degradable starch microspheres (DSM) in the treatment of non-resectable liver cancer. Acta Oncol. 1989;28(2):219–222. doi: 10.3109/02841868909111250. [DOI] [PubMed] [Google Scholar]
- Codde J. P., Burton M. A., Kelleher D. K., Archer S. G., Gray B. N. Reduced toxicity of adriamycin by incorporation into ion exchange microspheres: a therapeutic study using a rat liver tumour model. Anticancer Res. 1990 Nov-Dec;10(6):1715–1718. [PubMed] [Google Scholar]
- Dakhil S., Ensminger W., Cho K., Niederhuber J., Doan K., Wheeler R. Improved regional selectivity of hepatic arterial BCNU with degradable microspheres. Cancer. 1982 Aug 15;50(4):631–635. doi: 10.1002/1097-0142(19820815)50:4<631::aid-cncr2820500403>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
- Goldberg J. A., Kerr D. J., Wilmott N., McKillop J. H., McArdle C. S. Regional chemotherapy for colorectal liver metastases: a phase II evaluation of targeted hepatic arterial 5-fluorouracil for colorectal liver metastases. Br J Surg. 1990 Nov;77(11):1238–1240. doi: 10.1002/bjs.1800771114. [DOI] [PubMed] [Google Scholar]
- Grünwald J., Wischer W. Ultrastructural morphometry of cultivated smooth muscle cells from normotensive and hypertensive rats. Exp Pathol. 1985;27(2):91–98. doi: 10.1016/s0232-1513(85)80045-1. [DOI] [PubMed] [Google Scholar]
- Gyves J. W., Ensminger W. D., VanHarken D., Niederhuber J., Stetson P., Walker S. Improved regional selectivity of hepatic arterial mitomycin by starch microspheres. Clin Pharmacol Ther. 1983 Aug;34(2):259–265. doi: 10.1038/clpt.1983.163. [DOI] [PubMed] [Google Scholar]
- Kerr D. J., Willmott N., McKillop J. H., Cummings J., Lewi H. J., McArdle C. S. Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration. Cancer. 1988 Sep 1;62(5):878–883. doi: 10.1002/1097-0142(19880901)62:5<878::aid-cncr2820620505>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- McArdle C. S., Lewi H., Hansell D., Kerr D. J., McKillop J., Willmott N. Cytotoxic-loaded albumin microspheres: a novel approach to regional chemotherapy. Br J Surg. 1988 Feb;75(2):132–134. doi: 10.1002/bjs.1800750214. [DOI] [PubMed] [Google Scholar]
- Pfeifle C. E., Howell S. B., Bookstein J. J. Pilot study of intra-arterial floxuridine, mitomycin and doxorubicin in combination with degradable starch microspheres to treat primary and metastatic tumors of the liver. Cancer Drug Deliv. 1985 Fall;2(4):305–311. doi: 10.1089/cdd.1985.2.305. [DOI] [PubMed] [Google Scholar]